Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 6502-6507

  Ehret, Andreas ^a   Westendorp, Michael O ^a   Herr, Ingrid ^b   Debatin, Klaus Michael ^b   Heeney, Jonathan L ^c   Frank, Rainer ^d   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; TRANSACTIVATOR PROTEIN; [7 CHLORO 5 (1H PYRROL 2 YL) 3H BENZO[E][1,4]DIAZEPIN 2 YL]METHYLAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CHIMPANZEE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE DEPLETION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSACTIVATION;

EID: 0029818586     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.6502-6507.1996     Document Type: Article

References (26)

1. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R.-P. Sekaly, and T. H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activalion-induced apoptosis. J. Exp. Med. 176:1099-1106.
2. Bäumler, C. B., I. Herr, T. Böhler, P. H. Krammer, and K.-M. Debatin. Increased CD95 (APO- 1/Fas) ligand expression in T cells of HIV-1 infected children. Blood, in press.
3. Braddock, M., P. Cannon, M. Muckenthaler, A. J. Kingsman, and S. M. Kingsman. 1994. Inhibition of human immunodeficiency virus type 1 Tatdependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequences. J. Virol. 68:25-33.
4. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
5. Debatin, K. M., A. Fahrig-Fraissner, S. Enenkel-Stoodt, W. Kreuz, A. Benner, and P. H. Krammer. 1994. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 83:3101-3103.
6. Dhein, J., H. Walczak, C. Bäumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature (London) 373:438-441.
7. Droge, W., K. K. Murthy, C. Stahl-Hennig, S. Hartung, R. Plesker, S. Rouse, E. Peterhans, R. Kinscherf, T. Fischbach, and H.-P. Eck. 1993. Plasma amino acid dysregulation after lentiviral infection. AIDS Res. Hum. Retroviruses 9:807-809.
8. Finkel, T. H., G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1:129-134.
9. Flores, S. C., J. C. Marecki, K. P. Harper, S. K. Bose, S. K. Nelson, and J. M. McCord. 1993. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl. Acad. Sci. USA 90:7632-7636.
10. Goudsmit, J., L. Smitt, W. J. A. Krone, J. van der Noordaa, C. J. Gibbs, L. G. Epstein, and D. C. Gajdusek. 1987. IgG response to human immunodeficiency virus in experimentally infected chimpanzees mimics the IgG response in humans. J. Infect. Dis. 155:327-330.
11. Gougeon, M. L. 1995. Programmed cell death and AIDS: significance, perspectives and unanswered questions. Cell Death Differ. 2:1-8.
12. Gougeon, M. L., S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet, and L. Montagnier. 1993. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Retroviruses 9:553-563.
13. Heeney, J. L. 1995. AIDS: a disease of impaired Th-cell renewal? Immunol. Today 16:515-520.
14. Heeney, J. L., R. Jonker, W. Koornstra. R. Dubbers, H. Nophuis, A. M. Di Rienzo, M.-L. Gougeon, and L. Montagnier. 1993. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J. Med. Primatol. 22:194-200.
15. Herr, I., L. Balemans, C. Bäumler, H. Walczak, and K.-M. Debatin. Monitoring of CD95(APO-1/Fas)ligand expression in human B- and T-cells by quantitative-RT-PCR. Submitted for publication.
16. Hsu, M-C, U. Dhingra, J. V. Early, M. Holly, D. Keith, C. M. Nalins, A. R. Richou, A. D. Schutt, S. Y. Tam, M. J. Potash, D. J. Volsky, and D. D. Richman. 1993. Inhibition of type 1 human immunodeficiency virus replication by a Tat antagonist to which the virus remains sensitive after prolonged exposure in vitro. Proc. Natl. Acad. Sci. USA 90:6395-6399.
17. Katsikis, P. D., E. S. Wunderlich, C. A. Smith, L. A. Herzenberg, and L. A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:2029-2036.
18. Kraft, M., M. O. Westendorp, P. H. Krammer, O. Schuckert, P. Bayer, P. Rösch, and R. W. Frank. 1995. HIV-1 Tat protein: chemical synthesis and structural characterisation, p. 349-350. In H. L. S. Maia (ed.), Peptides 1994. Escom, Leiden, The Netherlands.
19. Li, J. C., D. J. Friedman, C. Wang, V. Metelev, and A. B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tal protein. Science 268:429-431.
20. McCord, J. M., and I. Fridovich. 1969. The utility of Superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dismethyl sulfoxide, and oxygen. J. Biol. Chem. 244:6049-6063.
21. Peter, M. E., J. Dhein, A. Ehret, S. Hellbardt, H. Walczak, G. Moldenhauer, and P. H. Krammer. 1995. APO-1(CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int. Immunol. 7:1873-1877.
22. Schuitemaker, H., L. Meyaard, N. A. Kootstra, R. Dubbes, S. A. Otto, M. Tersmette, J. L. Heeney, and F. Miedema. 1993. Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotrophic variants. J. Infect. Dis. 168:1140-1147.
23. Stricker, K., E. Knipping, A. Benner, P. H. Krammer, and K.-M. Debatin. 1995. Anti-APO-1 (CD95) autoantibodies and T cell depletion in HIV-1 infected children. Submitted for publication.
24. Terai, C., R. S. Kornbluth, D. C. Pauza, D. D. Richman, and D. A. Carson. 1991. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1 J. Clin. Invest 87:1710-1715.
25. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.-M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mcdiatcd apoptosis by HIV-1 Tat and gp120. Nature (London) 375:497-500.
26. Westendorp, M. O., V. A. Shatrov, K. Schulze-Osthoff, R. Frank, M. Kraft, M. Los, P. H. Krammer, W. Droge, and V. Lehmann. 1995. HIV-1 Tat potentiates TNF-induced NF-KB activation and cytotoxicity by altering the cellular redox state. EMBO J. 14:546-554.